{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:30:17Z","timestamp":1791945017144,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004869","name":"University of M\u00fcnster","doi-asserted-by":"publisher","award":["I-SC212302"],"award-info":[{"award-number":["I-SC212302"]}],"id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004869","name":"University of M\u00fcnster","doi-asserted-by":"publisher","award":["I-SC122105"],"award-info":[{"award-number":["I-SC122105"]}],"id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["CRU243 P4"],"award-info":[{"award-number":["CRU243 P4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1009 B13"],"award-info":[{"award-number":["SFB1009 B13"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["CRU342 P6"],"award-info":[{"award-number":["CRU342 P6"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1009 C4"],"award-info":[{"award-number":["SFB1009 C4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.drup.2026.101357","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:16:18Z","timestamp":1769040978000},"page":"101357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inhibitors of cellular RSK isoforms exhibit anti-SARS-CoV-2 activity, enhance efficacy of direct-acting antivirals, and suppress emergence of resistance"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-8894","authenticated-orcid":false,"given":"Andr\u00e9","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8882-5143","authenticated-orcid":false,"given":"Benjamin","family":"Ambrosy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darisuren","family":"Anhlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8826-3439","authenticated-orcid":false,"given":"Stefan","family":"Bletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-3052","authenticated-orcid":false,"given":"Stephan","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101357_bib1","first-page":"121","article-title":"Verapamil has Antiviral Activities that Target Different Steps of the Influenza Virus Replication Cycle","volume":"08","author":"Alam","year":"2016","journal-title":"J. Antivir. Antiretrovir"},{"key":"10.1016\/j.drup.2026.101357_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrm2509","article-title":"The RSK family of kinases: Emerging roles in cellular signalling","author":"Anjum","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2026.101357_bib3","series-title":"Studies to Combat COVID-19 Using Science and Engineering","first-page":"149","article-title":"Antiviral Drugs, Antibodies, and Vaccines for COVID-19","author":"Barry","year":"2022"},{"key":"10.1016\/j.drup.2026.101357_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41980","article-title":"SARS-CoV-2 drug resistance and therapeutic approaches","author":"Batool","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.drup.2026.101357_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MAJ.0b013e3181cb4487","article-title":"ADAM-17 is activated by the mitogenic protein kinase ERK in a model of kidney fibrosis","volume":"339","author":"Bell","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.drup.2026.101357_bib6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/cid\/ciad085","article-title":"Successful Combination Treatment for Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"76","author":"Blennow","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2026.101357_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ymthe.2020.12.016","article-title":"Synergistic and Antagonistic Drug Combinations against SARS-CoV-2","volume":"29","author":"Bobrowski","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drup.2026.101357_bib8","doi-asserted-by":"crossref","first-page":"26115","DOI":"10.1074\/jbc.M313509200","article-title":"p53 induces NF-\u03baB activation by an I\u03baB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1","volume":"279","author":"Bohuslav","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101357_bib9","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1038\/s41467-021-26239-2","article-title":"Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19","volume":"12","author":"Boras","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101357_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106510","article-title":"Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study","volume":"91","author":"Breuer","year":"2025","journal-title":"J. Infect."},{"key":"10.1016\/j.drup.2026.101357_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091400","article-title":"Combination therapy with fluoxetine and the nucleoside analog gs-441524 exerts synergistic antiviral effects against different sars-cov-2 variants in vitro","volume":"13","author":"Brunotte","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2026.101357_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.celrep.2017.09.074","article-title":"Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17\/TACE","volume":"21","author":"Cavadas","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101357_bib13","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.18632\/oncotarget.27630","article-title":"RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit","volume":"11","author":"Chae","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101357_bib14","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.1074\/jbc.M611322200","article-title":"RSK2 mediates muscle cell differentiation through regulation of NFAT3","volume":"282","author":"Cho","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101357_bib15","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1074\/jbc.273.3.1496","article-title":"Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a\/p90(rsk) that are inducible by MAPK","volume":"273","author":"Dalby","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101357_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070655","article-title":"ADME and pharmacokinetic properties of remdesivir: Its drug interaction potential","author":"Deb","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drup.2026.101357_bib17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/v17050722","article-title":"Evolution of Antiviral Drug Resistance in SARS-CoV-2","volume":"17","author":"Dinata","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.drup.2026.101357_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/dmd.121.000801","article-title":"Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans","volume":"50","author":"Eng","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drup.2026.101357_bib19","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201880","article-title":"ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection","volume":"6","author":"Engler","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.drup.2026.101357_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06902-1","article-title":"Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report","volume":"21","author":"Fenaux","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drup.2026.101357_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107552","article-title":"A stepwise and digital pattern of RSK phosphorylation determines the outcome of thymic selection","volume":"26","author":"Funasaki","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.drup.2026.101357_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101357_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1751-7176.2010.00397.x","article-title":"Combination Therapy in Hypertension","volume":"13","author":"Gradman","year":"2010","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.drup.2026.101357_bib24","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1074\/jbc.M601302200","article-title":"Role of NF-\u03baB in regulation of PXR-mediated gene expression: A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents","volume":"281","author":"Gu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101357_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.antiviral.2013.03.006","article-title":"Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro","volume":"98","author":"Haasbach","year":"2013","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101357_bib27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/infdis\/jiad270","article-title":"Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)","volume":"228","author":"Hedskog","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2026.101357_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000151","article-title":"Recruitment and activation of RSK2 by HIV-1 Tat","volume":"2","author":"Hetzer","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2026.101357_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.medj.2023.08.001","article-title":"Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2","volume":"4","author":"Hirotsu","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.drup.2026.101357_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/ciac769","article-title":"Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019","volume":"76","author":"Hogan","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2026.101357_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157524","article-title":"Icariin rescues immune dysfunction in sepsis through RSK2-driven YAP-cGAS-IFN-\u03b2 signaling activation","volume":"149","author":"Huang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drup.2026.101357_bib32","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drup.2026.101357_bib33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s42256-019-0122-4","article-title":"Prediction of drug combination effects with a minimal set of experiments","volume":"1","author":"Ianevski","year":"2019","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.drup.2026.101357_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106264","article-title":"Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases","volume":"242","author":"Ichikawa","year":"2025","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47941-x","article-title":"Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19","volume":"15","author":"Igari","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101357_bib36","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","author":"Iketani","year":"2022","journal-title":"Nature 12"},{"key":"10.1016\/j.drup.2026.101357_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc2214302","article-title":"Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB","volume":"388","author":"Imai","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101357_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.drup.2026.101357_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgaf085","article-title":"Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients","volume":"4","author":"Iriyama","year":"2025","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.drup.2026.101357_bib40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101357_bib41","doi-asserted-by":"crossref","first-page":"27168","DOI":"10.1074\/jbc.274.38.27168","article-title":"90-kDa Ribosomal S6 Kinase Is Phosphorylated and Activated by 3-Phosphoinositide-dependent Protein Kinase-1","volume":"274","author":"Jensen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101357_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105430","article-title":"Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice","volume":"208","author":"Jeong","year":"2022","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib43","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154305","article-title":"ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion","volume":"23","author":"Jocher","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2026.101357_bib44","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/JVI.02416-08","article-title":"Mitogen-Activated Protein Kinase-Activated Kinase RSK2 Plays a Role in Innate Immune Responses to Influenza Virus Infection","volume":"83","author":"Kakugawa","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2026.101357_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/srep36134","article-title":"RSK1 protects P-glycoprotein\/ABCB1 against ubiquitin-proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1","volume":"6","author":"Katayama","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101357_bib46","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1535-7163.MCT-07-0148","article-title":"Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein","volume":"6","author":"Katayama","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101357_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.antiviral.2017.06.006","article-title":"Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants","volume":"144","author":"Khandelwal","year":"2017","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110218","article-title":"The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance","volume":"38","author":"Kimura","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101357_bib49","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1128\/JVI.02119-07","article-title":"Activation of p90 Ribosomal S6 Kinase by ORF45 of Kaposi\u2019s Sarcoma-Associated Herpesvirus and Its Role in Viral Lytic Replication","volume":"82","author":"Kuang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2026.101357_bib50","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1074\/jbc.M900025200","article-title":"Mechanism of sustained activation of Ribosomal S6 Kinase (RSK) and ERK by Kaposi Sarcoma-associated herpesvirus ORF45: Multiprotein complexes retain active phosphorylated ERK and RSK and protect them from dephosphorylation","volume":"284","author":"Kuang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101357_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106006","article-title":"Identification of antibody-resistant SARS-CoV-2 mutants via N4-Hydroxycytidine mutagenesis","volume":"231","author":"Kumar","year":"2024","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/23744235.2018.1445281","article-title":"Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017","volume":"50","author":"Lagging","year":"2018","journal-title":"Infect. Dis."},{"key":"10.1016\/j.drup.2026.101357_bib53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S2468-1253(20)30158-8","article-title":"Wastewater monitoring of SARS-CoV-2: lessons from illicit drug policy","volume":"5","author":"Lancaster","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2026.101357_bib54","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1158\/1535-7163.MCT-16-0794","article-title":"Combinatorial screening of pancreatic adenocarcinoma reveals sensitivity to drug combinations including bromodomain inhibitor plus neddylation inhibitor","volume":"16","author":"Langdon","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101357_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104806","article-title":"Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model","volume":"178","author":"Laure","year":"2020","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-025-01543-3","article-title":"RSK2 and its binding partners: an emerging signaling node in cancers","author":"Lee","year":"2025","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.drup.2026.101357_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCRESAHA.112.276162","article-title":"Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy","volume":"112","author":"Li","year":"2013","journal-title":"Circ. Res"},{"key":"10.1016\/j.drup.2026.101357_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1010123","article-title":"RSK1 SUMOylation is required for KSHV lytic replication","volume":"17","author":"Liu","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2026.101357_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1011042","article-title":"Cardiovirus leader proteins retarget RSK kinases toward alternative substrates to perturb nucleocytoplasmic traffic","volume":"18","author":"Lizcano-Perret","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2026.101357_bib60","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1593\/neo.131660","article-title":"Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer","volume":"15","author":"Milosevic","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2026.101357_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade8778","article-title":"Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors","volume":"9","author":"Moghadasi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2026.101357_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-51924-3","article-title":"Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections","volume":"15","author":"Nooruzzaman","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101357_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103004","article-title":"Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease","volume":"299","author":"Noske","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101357_bib64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/pbc.24675","article-title":"Overcoming resistance to sonic hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma","volume":"61","author":"Pambid","year":"2014","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.drup.2026.101357_bib65","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hon.3206","article-title":"Dual combined antiviral treatment with remdesivir and nirmatrelvir\/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection","volume":"41","author":"Pasquini","year":"2023","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101357_bib66","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1096\/fj.09-151290","article-title":"RSK2 mediates NF-\u03baB activity through the phosphorylation of I\u03baB\u03b1 in the TNF-R1 pathway","volume":"24","author":"Peng","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2026.101357_bib67","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.00976-10","article-title":"Combinatorial approaches to the prevention and treatment of HIV-1 infection","volume":"55","author":"Pirrone","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2026.101357_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2005.01.005","article-title":"Predicting drug response and toxicity based on gene polymorphisms","author":"Robert","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.drup.2026.101357_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01238-24","article-title":"SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants","volume":"69","author":"Rodriguez","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2026.101357_bib70","article-title":"S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters","volume":"15","author":"Sasaki","year":"2022"},{"key":"10.1016\/j.drup.2026.101357_bib71","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/bph.15418","article-title":"Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro","volume":"178","author":"Schloer","year":"2021","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.drup.2026.101357_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012624","article-title":"Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection","volume":"20","author":"Schoefbaenker","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2026.101357_bib73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2018.07.006","article-title":"The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression","volume":"157","author":"Schr\u00e4der","year":"2018","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib74","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/pharmaceutics14091776","article-title":"The MEK1\/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs","volume":"14","author":"Schreiber","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2026.101357_bib75","doi-asserted-by":"crossref","first-page":"16557","DOI":"10.1073\/pnas.2002828117","article-title":"Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes","volume":"117","author":"Schreiber","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101357_bib76","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2471022","article-title":"Influenza H5Nx viruses are susceptible to MEK1\/2 inhibition by zapnometinib","volume":"14","author":"Schreiber","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.drup.2026.101357_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105840","article-title":"The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance","volume":"225","author":"Schreiber","year":"2024","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-021-04085-1","article-title":"The MEK1\/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine\/chemokine responses","volume":"79","author":"Schreiber","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drup.2026.101357_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2114647119","article-title":"A case of convergent evolution: Several viral and bacterial pathogens hijack RSK kinases through a common linear motif","volume":"119","author":"Sorgeloos","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101357_bib80","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41418-021-00916-7","article-title":"SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1","volume":"29","author":"Sun","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drup.2026.101357_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105671","article-title":"Assessment of the frequency of SARS-CoV-2 Omicron variant escape from RNA-dependent RNA polymerase inhibitors and 3C-like protease inhibitors","volume":"216","author":"Takashita","year":"2023","journal-title":"Antivir. Res"},{"key":"10.1016\/j.drup.2026.101357_bib82","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35431","article-title":"Emerging SARS-CoV-2 Resistance After Antiviral Treatment","volume":"7","author":"Tamura","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drup.2026.101357_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s11904-025-00744-1","article-title":"Future of bNAbs in HIV Treatment","volume":"22","author":"Tebas","year":"2025","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.drup.2026.101357_bib84","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/cid\/ciac847","article-title":"Dual Antiviral Therapy for Persistent Coronavirus Disease 2019 and Associated Organizing Pneumonia in an Immunocompromised Host","volume":"76","author":"Trottier","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2026.101357_bib85","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1096\/fj.09-137646","article-title":"Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK\/RSK90 activation and histone acetylation","volume":"24","author":"Wang","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2026.101357_bib86","article-title":"Key mutations in the spike protein of SARS-CoV-2 affecting neutralization resistance and viral internalization","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med Virol."},{"key":"10.1016\/j.drup.2026.101357_bib87","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-012-2105-0","article-title":"The role of genetics in drug dosing","author":"Ware","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.drup.2026.101357_bib88","series-title":"WHO COVID-19 dashboard [WWW Document]","author":"WHO","year":"2025"},{"key":"10.1016\/j.drup.2026.101357_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01233-24","article-title":"Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains","volume":"69","author":"Woodall","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2026.101357_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002972","article-title":"Phosphorylation of the Chromatin Binding Domain of KSHV LANA","volume":"8","author":"Woodard","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2026.101357_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1297292","article-title":"Therapeutic targeting of p90 ribosomal S6 kinase","author":"Wright","year":"2023","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.drup.2026.101357_bib92","article-title":"Why is the SARS-CoV-2 Omicron variant milder?","volume":"3","author":"Xia","year":"2022","journal-title":"Innovation"},{"issue":"1979","key":"10.1016\/j.drup.2026.101357_bib93","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.273.5277.959","article-title":"Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase","volume":"273","author":"Xing","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101357_bib94","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41374-021-00610-9","article-title":"Advanced oxidation protein products downregulate CYP1A2 and CYP3A4 expression and activity via the NF-\u03baB-mediated signaling pathway in vitro and in vivo","volume":"101","author":"Xun","year":"2021","journal-title":"Lab. Investig."},{"key":"10.1016\/j.drup.2026.101357_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/v16050718","article-title":"Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019","volume":"16","author":"Yamamoto","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.drup.2026.101357_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.12889","article-title":"Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir","author":"Yan","year":"2023","journal-title":"Fundam. Clin. Pharm."},{"key":"10.1016\/j.drup.2026.101357_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1015665","article-title":"RSK1 and RSK2 serine\/threonine kinases regulate different transcription programs in cancer","volume":"10","author":"Yang","year":"2023","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.drup.2026.101357_bib98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12885-024-11892-9","article-title":"p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer","volume":"24","author":"Yassin-Kassab","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2026.101357_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122973","article-title":"A novel protein\u2013protein interaction between rsk3 and i\u03bab\u03b1 and a new binding inhibitor that suppresses breast cancer tumorigenesis","volume":"13","author":"Yoon","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2026.101357_bib100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13046-022-02427-w","article-title":"CD147 mediates epidermal malignant transformation through the RSK2\/AP-1 pathway","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101357_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.adl4013","article-title":"In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2026.101357_bib102","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciad494","article-title":"Nirmatrelvir Resistance\u2014de Novo E166V\/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir\/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure\u2014a Case Report","volume":"78","author":"Zuckerman","year":"2024","journal-title":"Clin. Infect. Dis."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:33:06Z","timestamp":1774020786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":102,"alternative-id":["S1368764626000087"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101357","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of cellular RSK isoforms exhibit anti-SARS-CoV-2 activity, enhance efficacy of direct-acting antivirals, and suppress emergence of resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101357"}}